Literature DB >> 3082974

T cell-monocyte interactions in the production of humoral factors regulating human granulopoiesis in vitro.

F Herrmann, S A Cannistra, J D Griffin.   

Abstract

A variety of monocyte functions are modulated by the T cell lymphokine interferon-gamma (IFN-gamma). We assessed the capacity of IFN-gamma to induce release of granulocyte-monocyte stimulating factors (CSF-GM) from highly purified monocyte preparations. Whereas secretion of CSF-GM by monocytes is negligible in the absence of T cells, CSF-GM secretion is inducible when concentrations of IFN-gamma as low as 10 U/ml are present. This effect could be abrogated by specific neutralizing monoclonal antibody to IFN-gamma and was restricted to monocytes, as resting T cells failed to secrete detectable CSF-GM in response to IFN-gamma. The response of monocyte preparations to IFN-gamma was biphasic in that concentrations greater than 250 U/ml did not induce detectable CSF-GM activity. However, this was shown to be due to the release of a humoral inhibitor of G/M-progenitor cells, and not necessarily due to a lack of CSF-GM secretion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082974

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin.

Authors:  H E Broxmeyer; L Lu; S Cooper; R H Schwall; A J Mason; K Nikolics
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

2.  Granulocyte Colony-stimulating Factor Producing Oropharyngeal Squamous Cell Carcinoma.

Authors:  Gregory Schurmann; Martin Zweifel; Roland Giger; Tilman T Rau; Sarah Vinzens; Matthias S Dettmer; Yojena Kurian
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

3.  Interleukin-4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes.

Authors:  J A Hamilton; G A Whitty; A K Royston; J Cebon; J E Layton
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

4.  Weight loss in patients with hematological neoplasias is associated with immune system stimulation.

Authors:  H Denz; B Orth; G Weiss; R Herrmann; P Huber; H Wachter; D Fuchs
Journal:  Clin Investig       Date:  1993-01

5.  Human granulocyte-macrophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes.

Authors:  S A Cannistra; A Rambaldi; D R Spriggs; F Herrmann; D Kufe; J D Griffin
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

6.  Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor 1, recombinant murine interleukin 3, and recombinant murine granulocyte/macrophage colony-stimulating factor.

Authors:  H E Broxmeyer; D E Williams; G Hangoc; S Cooper; S Gillis; R K Shadduck; D C Bicknell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

7.  Interleukin 1 stimulates T lymphocytes to produce granulocyte-monocyte colony-stimulating factor.

Authors:  F Herrmann; W Oster; S C Meuer; A Lindemann; R H Mertelsmann
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

8.  Granulocyte-macrophage colony-stimulating factor is not involved in production of reactive nitrogen intermediates by or toxoplasmastatic activity of gamma interferon-activated murine macrophages.

Authors:  A Buisman; J T van Dissel; J A Langermans; R van Furth
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

9.  Effect of human macrophage colony-stimulating factor on granulopoiesis and survival in bone-marrow-transplanted mice.

Authors:  N Yanai; M Yamada; K Motoyoshi; H Yokota; K Yoshida; M Saito; T Kawashima; M Nishida; Y Miura; M Saito
Journal:  Jpn J Cancer Res       Date:  1990-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.